Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: CellaVision AB

Market Cap 3.13B 332M 287M 264M 247M 464M 31.84B 471M 1.22B 15.36B 1.25B 1.22B 53.55B P/E Ratio 2026 *
21.6x
P/E Ratio 2027 * 18x
Enterprise Value 2.92B 309M 267M 245M 230M 432M 29.62B 438M 1.13B 14.29B 1.16B 1.14B 49.82B EV / Sales 2026 *
3.78x
EV / Sales 2027 * 3.33x
Free-Float
83.08%
Yield 2026 *
2.09%
Yield 2027 * 2.34%
1 day+4.29%
1 week+8.77%
Current month+8.96%
1 month+10.98%
3 months-13.32%
6 months-13.78%
Current year-16.41%
1 week 122
Extreme 122
133.6
1 month 118.2
Extreme 118.2
133.6
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
199.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 52.5
Extreme 52.5
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-09Buy

Director

314 0.0013%
06-08Buy

Executive/Senior Manager

10,000 0.0419%
04-28Buy

Founder

230,000 0.9643%
Change 5-day change 1-year change 3-year change Capi.($)
+4.29%+8.77%-34.10%-38.16% 317M
-2.50%-5.57%+10.45%-29.84% 16.91B
+6.03%-1.29%+30.18%+60.84% 1.57B
-0.32%0.00%-30.18%+19.55% 1.12B
+4.37%+3.60%-54.43%-83.37% 921M
-1.20%-5.89%-25.62%-55.23% 643M
-0.07%-5.93%-47.62%-59.63% 561M
+4.75%+8.67%+23.79%-51.45% 444M
+0.47%-1.09%-55.54%-60.17% 390M
+4.62%-5.64%+48.36% - 324M
Average +2.04%-0.36%-13.47%-33.05% 2.32B
Weighted average by Cap. -1.07%-2.22%+3.91%-25.85%

Financials

2026 *2027 *
Net sales 772M 81.79M 70.6M 64.95M 60.91M 114M 7.84B 116M 300M 3.78B 307M 301M 13.18B 862M 91.42M 78.91M 72.59M 68.08M 128M 8.76B 130M 335M 4.23B 343M 336M 14.73B
Net income 145M 15.36M 13.26M 12.2M 11.44M 21.45M 1.47B 21.79M 56.3M 710M 57.72M 56.47M 2.48B 174M 18.46M 15.93M 14.66M 13.75M 25.77M 1.77B 26.18M 67.65M 854M 69.35M 67.85M 2.98B
Net Debt -218M -23.13M -19.97M -18.37M -17.23M -32.3M -2.22B -32.81M -84.77M -1.07B -86.91M -85.03M -3.73B -266M -28.19M -24.33M -22.38M -20.99M -39.36M -2.7B -39.99M -103M -1.3B -106M -104M -4.54B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
11/06/26 131.40 kr +4.29% 60,254
10/06/26 126.00 kr -0.16% 52,421
09/06/26 126.20 kr -1.71% 59,964
08/06/26 128.40 kr +1.90% 186,011
05/06/26 126.00 kr +2.27% 206,267
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
131.40SEK
Average target price
179.00SEK
Spread / Average Target
+36.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!